510(k) K020234
K020234 is an FDA 510(k) premarket notification submitted by Metrika, Inc. for the device "A1CNOW FOR RX HOME USE". The FDA issued a decision of Substantially Equivalent on February 15, 2002. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Metrika, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 15, 2002
- Date Received
- January 23, 2002
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type